首页> 外文期刊>Pediatric transplantation. >Endoscopic retrograde cholangiopancreatography is safe and effective for the diagnosis and treatment of pancreaticobiliary disease following abdominal organ transplant in children.
【24h】

Endoscopic retrograde cholangiopancreatography is safe and effective for the diagnosis and treatment of pancreaticobiliary disease following abdominal organ transplant in children.

机译:内镜逆行胰胆管造影术对儿童腹部器官移植术后胰腺胆道疾病的诊断和治疗是安全有效的。

获取原文
获取原文并翻译 | 示例
           

摘要

Otto AK, Neal MD, Mazariegos GV, Slivka A, Kane TD. Endoscopic retrograde cholangiopancreatography is safe and effective for the diagnosis and treatment of pancreaticobiliary disease following abdominal organ transplant in children. Abstract:? ERCP is a diagnostic and therapeutic imaging modality widely used in adult pancreaticobiliary disease, including the treatment of anastomotic strictures following liver and small bowel transplant. We have previously reported a large series of ERCP in children and demonstrated its safety and utility in pediatric disease. The aim of this study was to evaluate the safety of and indications for ERCP following abdominal organ transplant among pediatric patients by performing a subgroup analysis of our large cohort. Forty-eight ERCPs were performed on 25 children ages 62?days to 20?yr following isolated liver, isolated small bowel, or composite graft transplant. Mean time from transplantation at the time of ERCP was 18?months. The most common indication for ERCP was the evaluation of non-specific hepatobiliary complaints, including abdominal pain and elevated liver enzymes. ERCP was also commonly performed for the evaluation or treatment of known or suspected biliary tree strictures. Seventy-seven percent of cases included therapeutic intervention, including sphincterotomy in 40%, stent placement in 29%, and stone extraction in 19%. The overall complication rate among post-transplant patients was low (2.9%) and not significantly different than the complication rate reported in our previous study. A history of abdominal organ transplant was not associated with an increased risk of complication following ERCP (OR?=?0.41, 95% CI?=?0.05-3.33). In our experience, ERCP can be safely performed in children following liver, small bowel, and composite graft transplant with outcomes similar to those seen in a general pediatric population and may be especially useful for the diagnosis and treatment for biliary strictures following transplant. Further investigation of the relationship between the timing of ERCP relative to transplant and the safety of the procedure is needed.
机译:奥托(Otto)AK,尼尔(Neal)医师,马扎里埃戈斯(Mazariegos GV),斯利夫卡(Slivka)A,凯恩(Kane)。内镜逆行胰胆管造影术对儿童腹部器官移植术后胰腺胆道疾病的诊断和治疗是安全有效的。抽象:? ERCP是一种诊断和治疗成像方式,广泛用于成人胰胆管疾病,包括肝和小肠移植术后的吻合口狭窄治疗。我们先前已经报道了儿童中的大量ERCP,并证明了其在儿科疾病中的安全性和实用性。这项研究的目的是通过对我们的大型队列进行亚组分析,评估小儿患者腹部器官移植后ERCP的安全性和适应症。在孤立的肝脏,孤立的小肠或复合移植物移植后,对25位62岁至20岁的儿童进行了48次ERCP。 ERCP手术后的平均移植时间为18个月。 ERCP的最常见指征是对非特异性肝胆疾病的评估,包括腹痛和肝酶升高。 ERCP通常也用于评估或治疗已知或怀疑的胆道狭窄。 77%的病例包括治疗性干预,包括40%的括约肌切开术,29%的支架置入和19%的结石摘除。移植后患者的总体并发症发生率较低(2.9%),与我们先前的研究报告的并发症发生率没有显着差异。腹部器官移植病史与ERCP术后并发症风险增加无关(OR = 0.41,95%CI = 0.05-3.33)。根据我们的经验,ERCP可以在肝,小肠和复合材料移植后的儿童中安全地进行,其结局与普通儿科人群中观察到的结果相似,并且对于诊断和治疗移植后胆道狭窄尤其有用。需要进一步研究ERCP相对于移植的时机与手术安全性之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号